Natural Language Processing Platform for Cancer Surveillance

用于癌症监测的自然语言处理平台

基本信息

  • 批准号:
    10441803
  • 负责人:
  • 金额:
    $ 66.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-19 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Modified Project Summary/Abstract Section This UG3/UH3 proposal titled “Natural Language Processing Platform for Cancer Surveillance” is in response to Research Area 1 of PAR 16-349 (https://grants.nih.gov/grants/guide/pa-files/par-16-349.html) specifically addressing the development of natural language processing (NLP) tools to facilitate automatic/unsupervised/minimally supervised extraction of specific discrete cancer-related data from various types of unstructured electronic medical records (EMRs) related to the activities of cancer registries. It is submitted through a multi-PI mechanism – Prof. Guergana Savova from Boston Children’s Hospital/Harvard Medical School, Dr. Jeremy Warner from Vanderbilt University Medical Center, Prof. Harry Hochheiser from the University of Pittsburgh, and Prof. Eric Durbin from the Kentucky Cancer Registry/University of Kentucky. The current proposal builds on prior work funded by the NCI Informatics Tools for Cancer Research (ITCR) program (https://itcr.cancer.gov/ ). We envision building on our work to date to advance methods for information extraction of clinical phenotyping data needed to fuel a new cancer surveillance paradigm that would benefit hospital-based, state-based, and national cancer registries. In this new paradigm, surveillance programs would use the methods to enhance the speed, accuracy, and ease of cancer reporting. The proposed DeepPhe*CR platform could be deployed at local sites or centrally, and could eventually be integrated into existing or new visualization and abstraction tools as needed by the cancer surveillance community. Although there has been some previous work on automatic phenotype extraction from the various streams of data including the clinical narrative for specific types of cancer or individual variables for cancer surveillance, the proposed work will be a step towards a generalizable information extraction. This generalizability enables extensibility and scalability. Interoperability is reinforced through the modeling part of the proposed project which is grounded in most recent advances in biomedical ontologies, terminologies, community-adopted conventions and standards. Our planned partnership with three SEER cancer registries provides our decision-making processes with a solid foundation in large-scale cancer surveillance.
修改项目摘要/摘要部分 UG 3/UH 3提案标题为“用于癌症监测的自然语言处理平台”,是对PAR 16-349研究领域1(https://grants.nih.gov/grants/guide/pa-files/par-16-349.html)的响应,该研究领域1专门针对自然语言处理(NLP)工具的开发,以促进从与癌症登记活动相关的各种类型的非结构化电子病历(EMR)中自动/无监督/最低监督提取特定离散癌症相关数据。通过多PI机制提交-来自波士顿儿童医院/哈佛医学院的Guergana Savova教授、来自范德比尔特大学医学中心的Jeremy Warner博士、来自匹兹堡大学的Harry Hochheiser教授和来自肯塔基州癌症登记处/肯塔基州大学的Eric Durbin教授。目前的提案建立在NCI癌症研究信息学工具(ITCR)计划(https://www.example.com)资助的先前工作的基础上。itcr.cancer.gov/我们设想在我们迄今为止的工作的基础上,推进临床表型数据的信息提取方法,以推动新的癌症监测范式,这将有利于医院,州和国家癌症登记。在这种新的模式中,监测项目将使用这些方法来提高癌症报告的速度、准确性和便利性。拟议的DeepPhe*CR平台可以部署在本地站点或集中部署,最终可以根据癌症监测社区的需要集成到现有或新的可视化和抽象工具中。虽然已经有一些以前的工作自动表型提取的各种数据流,包括特定类型的癌症或癌症监测的个体变量的临床叙述,拟议的工作将是一个可推广的信息提取的一步。这种通用性支持可扩展性和可伸缩性。通过拟议项目的建模部分加强了互操作性,该项目基于生物医学本体、术语、社区采用的惯例和标准的最新进展。我们计划与三个SEER癌症登记处建立伙伴关系,为我们的决策过程提供了大规模癌症监测的坚实基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric B. Durbin其他文献

Eric B. Durbin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric B. Durbin', 18)}}的其他基金

Natural Language Processing Platform for Cancer Surveillance
用于癌症监测的自然语言处理平台
  • 批准号:
    10451798
  • 财政年份:
    2019
  • 资助金额:
    $ 66.02万
  • 项目类别:
Natural Language Processing Platform for Cancer Surveillance
用于癌症监测的自然语言处理平台
  • 批准号:
    9980862
  • 财政年份:
    2019
  • 资助金额:
    $ 66.02万
  • 项目类别:
Natural Language Processing Platform for Cancer Surveillance
用于癌症监测的自然语言处理平台
  • 批准号:
    10589385
  • 财政年份:
    2019
  • 资助金额:
    $ 66.02万
  • 项目类别:
Natural Language Processing Platform for Cancer Surveillance
用于癌症监测的自然语言处理平台
  • 批准号:
    10656293
  • 财政年份:
    2019
  • 资助金额:
    $ 66.02万
  • 项目类别:
Methods and Tools for Integrating Pathomics Data into Cancer Registries
将病理组学数据整合到癌症登记处的方法和工具
  • 批准号:
    10216066
  • 财政年份:
    2018
  • 资助金额:
    $ 66.02万
  • 项目类别:
IGF::OT::IGF EXPANDING SEER TO INCLUDE MOLECULAR PROFILING IN NON-SMALL CELL LUNG CANCER (NSCLC)
IGF::OT::IGF 扩展 SEER 以包括非小细胞肺癌 (NSCLC) 的分子分析
  • 批准号:
    9161889
  • 财政年份:
    2015
  • 资助金额:
    $ 66.02万
  • 项目类别:
IGF::OT::IGF IMPROVE COMPLETENESS OF TREATMENT AND OTHER KEY DATA ELEMENTS BY LINKAGES WITH 15-MONTH RESUBMITTED DATA FROM COMMISSION ON CANCER HOSPITALS PERIOD OF PERFORMANCE: 09/18/2015 - 09/17/2016
IGF::OT::IGF 通过与癌症医院委员会重新提交的 15 个月数据的联系提高治疗和其他关键数据要素的完整性 执行期间:2015 年 9 月 18 日 - 2016 年 9 月 17 日
  • 批准号:
    9161894
  • 财政年份:
    2015
  • 资助金额:
    $ 66.02万
  • 项目类别:
ENHANCING CANCER REGISTRIES FOR EARLY CASE CAPTURE
加强癌症登记以实现早期病例捕获
  • 批准号:
    8886276
  • 财政年份:
    2014
  • 资助金额:
    $ 66.02万
  • 项目类别:
Cancer Research Informatics Shared Resource Facility
癌症研究信息学共享资源设施
  • 批准号:
    10204887
  • 财政年份:
    2013
  • 资助金额:
    $ 66.02万
  • 项目类别:
Cancer Research Informatics Shared Resource Facility
癌症研究信息学共享资源设施
  • 批准号:
    10470106
  • 财政年份:
    2013
  • 资助金额:
    $ 66.02万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了